These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8959560)

  • 21. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.
    Buljevic S; Detel D; Pucar LB; Mihelic R; Madarevic T; Sestan B; Varljen J
    Rheumatol Int; 2013 Nov; 33(11):2867-74. PubMed ID: 23864142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS.
    Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL
    Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors.
    Erić-Nikolić A; Matić IZ; Dorđević M; Milovanović Z; Marković I; Džodić R; Inić M; Srdić-Rajić T; Jevrić M; Gavrilović D; Cordero OJ; Juranić ZD
    Immunobiology; 2011 Aug; 216(8):942-6. PubMed ID: 21281985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.
    Hildebrandt M; Rose M; Mönnikes H; Reutter W; Keller W; Klapp BF
    Nutrition; 2001 Jun; 17(6):451-4. PubMed ID: 11399402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.
    Sromova L; Busek P; Sedova L; Sedo A
    BMC Musculoskelet Disord; 2015 Sep; 16():244. PubMed ID: 26353808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
    Guieu R; Fenouillet E; Devaux C; Fajloun Z; Carrega L; Sabatier JM; Sauze N; Marguet D
    Behav Brain Res; 2006 Jan; 166(2):230-5. PubMed ID: 16154213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
    van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
    Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
    Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
    Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.
    Firneisz G; Lakatos PL; Szalay F;
    Scand J Gastroenterol; 2001 Aug; 36(8):877-80. PubMed ID: 11495085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
    Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
    Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.
    Maes M; De Meester I; Verkerk R; De Medts P; Wauters A; Vanhoof G; Vandoolaeghe E; Neels H; Scharpé S
    Psychoneuroendocrinology; 1997 Feb; 22(2):65-78. PubMed ID: 9149329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease.
    Hildebrandt M; Rose M; Rüter J; Salama A; Mönnikes H; Klapp BF
    Scand J Gastroenterol; 2001 Oct; 36(10):1067-72. PubMed ID: 11589380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms.
    Lu HY; Huang CY; Shih CM; Lin YW; Tsai CS; Lin FY; Shih CC
    J Vasc Surg; 2017 Oct; 66(4):1217-1226.e1. PubMed ID: 27887857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
    Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.
    Lakatos PL; Firneisz G; Borcsiczky D; Zalatnai A; Selmeci L; Szalay F
    Eur J Clin Invest; 2000 Sep; 30(9):793-7. PubMed ID: 10998079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.